Cipla Buys Hetero Drugs US Business For $550 | MD Subhanu Saxena Gives Details - video Dailymotion

Name: Cipla Buys Hetero Drugs US Business For $550 | MD Subhanu Saxena Gives Details
Uploaded: 2015-09-07T06:31:57+00:00
Duration: 11 min 51 s
Channel: ET NOW
Description: Cipla logged healthy gains in trade after it acquired Hetero Drugs US business for $550 million earlier in the day. In an exclusive chat with ET NOW's Nikunj Dalmia, Subhanu Saxena - MD & Global CEO of Cipla said that the acquisition has potential to add $200 mn to the revenues this year. To know more on the deal, listen in to the man himself.

ET NOW

Cipla logged healthy gains in trade after it acquired Hetero Drugs US business for $550 million earlier in the day. In an exclusive chat with ET NOW's Nikunj Dalmia, Subhanu Saxena - MD & Global CEO of Cipla said that the acquisition has potential to add $200 mn to the revenues this year. To know more on the deal, listen in to the man himself.

Cipla Buys Hetero Drugs US Business For $550 | MD Subhanu Saxena Gives Details

Recommended